Empire Genomics | Amplification of 1q21 Linked to Poor Outcomes of Daratumumab-Based Treatments in Multiple Myeloma
Frontiers | The independent adverse prognostic significance of 1q21 gain/ amplification in newly diagnosed multiple myeloma patients
Table 3 from Prognostic Value of 1q21 Gain in Multiple Myeloma | Semantic Scholar
Cancers | Free Full-Text | Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis - Biology of Blood and Marrow Transplantation
![PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/021a0aec1b05c89b61b715a94f2a080ee380e896/2-Figure1-1.png "PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar")
PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome | Blood Cancer Journal
FISH patterns consistent with copy gain of the 1q21 genomic region that... | Download Scientific Diagram
Nicolas Thomas Iannozzi on LinkedIn: Gain and/or amplification of the 1q21 region (1q21+) is one of the most…
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/ amplification in the era of modern therapy | Annals of Hematology
Frontiers | Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens
![PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/021a0aec1b05c89b61b715a94f2a080ee380e896/5-Table1-1.png "PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar")
PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar
Cells | Free Full-Text | Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
Genetic Predictors of Mortality in Multiple Myeloma | TACG
Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value | Haematologica
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome | Blood Cancer Journal
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome. - Abstract - Europe PMC
Cancers | Free Full-Text | Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy - Biology of Blood and Marrow Transplantation
Chromosome 1q21 abnormalities in multiple myeloma | Blood Cancer Journal
Risk stratification of newly diagnosed multiple myeloma using chromosome 1
Cells | Free Full-Text | Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
Systems medicine dissection of chromosome 1q amplification reveals oncogenic regulatory circuits and informs targeted therapy in cancer | bioRxiv
Risk stratification of newly diagnosed multiple myeloma using chromosome 1
PRUNE1 (located on chromosome 1q21.3) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion,British Journal of Haematology - X-MOL
